GRI Bio (GRI) News Today 0.67 +0.03 (+4.87%) (As of 10:31 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)November 21 at 8:45 AM | globenewswire.comGRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary FibrosisNovember 14, 2024 | globenewswire.comGRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024October 24, 2024 | globenewswire.comGRI Bio (NASDAQ:GRI) Stock, Short Interest ReportOctober 23, 2024 | benzinga.comGRI Bio Announces Exercise of WarrantsOctober 21, 2024 | globenewswire.comDahlia HaleemOctober 18, 2024 | entrepreneur.comGRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621's Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)October 16, 2024 | globenewswire.comAscendiant Capital Initiates Coverage of GRI Bio (GRI) with Buy RecommendationOctober 9, 2024 | msn.comGRI Bio to Present at the 22nd International Colloquium on Lung and Airway FibrosisOctober 7, 2024 | markets.businessinsider.comGRI Bio Granted Japan Patent for Proprietary Natural Killer T (NKT) Cell Modulators for Prevention and Treatment of Inflammatory ConditionsSeptember 30, 2024 | globenewswire.comGRI Bio Receives Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in AustraliaSeptember 26, 2024 | markets.businessinsider.comGRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect SegmentSeptember 25, 2024 | globenewswire.comGRI Bio Participates in Virtual Investor KOL Connect SegmentSeptember 18, 2024 | finance.yahoo.comGRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 5, 2024 | globenewswire.comGRI Bio to Present at the 2024 European Respiratory CongressSeptember 4, 2024 | globenewswire.comGRI Bio Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 14, 2024 | globenewswire.comCompare with Russian Secured Funding Average Rate 1 Week Index (RUSFAR1W=RTS)August 13, 2024 | msn.comGRI Bio (NASDAQ:GRI) Stock Quotes, Forecast and News SummaryAugust 8, 2024 | benzinga.comGRI Bio, Inc. (GRI)July 19, 2024 | finance.yahoo.comGRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break SeriesJuly 15, 2024 | globenewswire.comGRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” SegmentJuly 11, 2024 | globenewswire.comGRI Bio Regains Compliance with NasdaqJuly 8, 2024 | globenewswire.comGRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care MedicineJuly 2, 2024 | globenewswire.comGRI Bio to Present at the 8th Annual IPF SummitJuly 1, 2024 | globenewswire.comGRI Bio Announces Closing of $4.0 Million Public OfferingJune 28, 2024 | globenewswire.comGRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell ModulatorsJune 27, 2024 | globenewswire.comWhy Is GRI Bio (GRI) Stock Down 29% Today?June 26, 2024 | investorplace.comGRI Bio Announces Reverse Stock SplitJune 14, 2024 | globenewswire.comGRI Bio (NASDAQ: GRI) Participates in Virtual Investor CEO ConnectMay 23, 2024 | finance.yahoo.comGRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) ProgramsMay 22, 2024 | globenewswire.comGRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)May 21, 2024 | globenewswire.comGRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)May 20, 2024 | finance.yahoo.comGRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)May 20, 2024 | globenewswire.comZiopharm: Q1 Earnings SnapshotMay 15, 2024 | washingtonpost.comGRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company ShowcaseMay 14, 2024 | finance.yahoo.comGRI Bio to Present at Alliance Global Partner's 2024 Healthcare Company ShowcaseMay 14, 2024 | globenewswire.comGRI Stock Earnings: GRI Bio Reported Results for Q1 2024May 13, 2024 | msn.comGRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 13, 2024 | globenewswire.comBabraham-based Harness Therapeutics appoints Meenu Chhabra Karson as board chairMay 2, 2024 | msn.comGRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on AutoimmunityApril 29, 2024 | globenewswire.comGRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarApril 25, 2024 | globenewswire.comGRI Bio, Inc.: GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea PatentApril 18, 2024 | finanznachrichten.deGRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea PatentApril 16, 2024 | globenewswire.comGRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International ConferenceApril 8, 2024 | globenewswire.comGRI Bio Reports Full Year 2023 Financial Results and Provides Corporate UpdateApril 1, 2024 | globenewswire.comGRI Bio to Present at the MedInvest Biotech & Pharma Investor ConferenceMarch 28, 2024 | globenewswire.comGRI Bio, Inc.: GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsMarch 14, 2024 | finanznachrichten.deGRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsMarch 14, 2024 | finance.yahoo.comGRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsMarch 14, 2024 | globenewswire.comGRI Bio, Inc.: GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United KingdomMarch 4, 2024 | finanznachrichten.de Get GRI Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. GRI Media Mentions By Week GRI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRI News Sentiment▼1.660.46▲Average Medical News Sentiment GRI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRI Articles This Week▼31▲GRI Articles Average Week Get GRI Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GLTO News BIOR News CANF News ABVC News SYRS News BCLI News GTBP News EDSA News EVOK News ADIL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRI Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRI Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRI Stock Alerts